Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1876567

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1876567

Omega-3 Fatty Acids Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Omega-3 Fatty Acids Market was valued at USD 3.2 billion in 2024 and is estimated to grow at a CAGR of 3.6% to reach USD 4.8 billion by 2034.

Omega-3 Fatty Acids Market - IMG1

The expanding body of scientific research highlighting the health advantages of omega-3 fatty acids is a major driver of market growth. With over 40,000 peer-reviewed studies on EPA and DHA, including thousands of clinical trials confirming their positive effects on cardiovascular, brain, and eye health, consumer awareness continues to rise. Increasing public awareness of preventive health and nutrition is fueling demand for omega-3 supplements, particularly those targeting heart and cognitive health. The broader interest in functional and fortified food products further propels the market, as food and beverage manufacturers integrate omega-3 ingredients into everyday items such as baked goods, dairy, and beverages. The move toward incorporating omega-3 into daily nutrition rather than relying solely on dietary supplements is expanding market applications and supporting long-term growth prospects across regions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.2 Billion
Forecast Value$4.8 Billion
CAGR3.6%

The algal-derived omega-3 segment is expected to grow at a CAGR of 3.9% through 2034, driven by strong consumer interest in sustainable and plant-based sources. The rapid advancement of microalgae cultivation technologies and increasing awareness of environmental concerns have boosted this category's appeal. Algal oil offers a cleaner and more concentrated source of EPA and DHA, enabling smaller doses and eliminating issues such as the fishy odor often associated with traditional marine-based omega-3 products. This advantage is helping plant-based alternatives gain greater traction in both dietary supplements and fortified food formulations.

In 2024, the general wellness and dietary supplements held a 24% share, reflecting strong consumer acceptance of omega-3 products for maintaining overall health and preventing chronic conditions. These categories continue to benefit from high accessibility through retail and online channels, although the clinical efficacy among different generic products remains variable. Functional foods and fortification represented around 16% of the market, supported by ongoing product innovation as manufacturers incorporate omega-3 into beverages, bakery items, and dairy products to meet consumer demand for nutritious and convenient options.

United States Omega-3 Fatty Acids Market was valued at USD 781.3 million in 2024 and is projected to reach USD 1.1 billion by 2034. North America represents a mature market environment, characterized by well-established supplement consumption habits and heightened consumer awareness of health and wellness benefits. The United States leads the regional market, holding around 83% of North American sales, supported by extensive retail distribution, direct-to-consumer marketing, and medical professional recommendations. The regulatory landscape in the U.S. remains stable, and consumer confidence is reinforced through FDA oversight and GRAS (Generally Recognized as Safe) certifications for omega-3 ingredients.

Key participants in the Global Omega-3 Fatty Acids Market include DSM-Firmenich, BASF SE, Croda International, Aker BioMarine, Archer Daniels Midland, Cargill, Corbion, Omega Protein Corporation, Epax, and KD Pharma Group. Leading players in the Omega-3 Fatty Acids Market are pursuing strategic initiatives to strengthen their market positions and expand global reach. Many are focusing on sustainable sourcing by investing in algal-based omega-3 production to reduce dependence on marine resources. Companies are also enhancing product quality through advanced purification technologies and optimizing EPA/DHA concentration levels to meet diverse consumer needs. Strategic mergers, acquisitions, and partnerships are helping major manufacturers expand supply networks and enter new regional markets.

Product Code: 15126

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Product Type
    • 2.2.2 Application
    • 2.2.3 End Use Industry
  • 2.3 TAM analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
  • 3.8 Future market trends
  • 3.9 Technology and innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East & Africa
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Size and Forecast, By Product Type, 2021-2034 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Marine-derived omega-3
    • 5.2.1 Fish oil
    • 5.2.2 Concentrated fish oil
    • 5.2.3 Krill oil & phospholipid forms
    • 5.2.4 Others
  • 5.3 Algal-derived omega-3
    • 5.3.1 Microalgae oil
    • 5.3.2 Fermentation-derived EPA & DHA
  • 5.4 Plant-based omega-3 (ALA)
    • 5.4.1 Flaxseed oil
    • 5.4.2 Chia seed oil
    • 5.4.3 Others
  • 5.5 Prescription omega-3 drugs
  • 5.6 Concentrated & purified forms

Chapter 6 Market Size and Forecast, By Application, 2021-2034 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Cardiovascular health
    • 6.2.1 Primary prevention products
    • 6.2.2 Secondary prevention formulations
    • 6.2.3 Blood pressure management
    • 6.2.4 Arrhythmia prevention
  • 6.3 Hypertriglyceridemia treatment
    • 6.3.1 Severe hypertriglyceridemia
    • 6.3.2 Moderate hypertriglyceridemia
  • 6.4 General wellness & dietary supplements
    • 6.4.1 Daily nutrition
    • 6.4.2 Brain health & cognitive function
    • 6.4.3 Eye health & vision support
    • 6.4.4 Joint health & inflammation
  • 6.5 Functional foods & fortification
    • 6.5.1 Dairy product
    • 6.5.2 Bakery & confectionery
    • 6.5.3 Beverage fortification
    • 6.5.4 Meat & poultry
  • 6.6 Infant & maternal nutrition
    • 6.6.1 Infant formula applications
    • 6.6.2 Prenatal & postnatal supplements
    • 6.6.3 Pediatric nutrition products
  • 6.7 Animal feed & aquaculture
    • 6.7.1 Aquaculture feed
    • 6.7.2 Pet food
    • 6.7.3 Livestock feed

Chapter 7 Market Size and Forecast, By End Use Industry, 2021-2034 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Pharmaceutical industry
  • 7.3 Nutraceutical & dietary supplement industry
  • 7.4 Food & beverage industry
  • 7.5 Animal feed industry

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Billion, Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 DSM-Firmenich
  • 9.2 BASF SE
  • 9.3 Croda International
  • 9.4 Aker BioMarine
  • 9.5 Archer Daniels Midland
  • 9.6 Cargill
  • 9.7 Corbion
  • 9.8 Omega Protein Corporation
  • 9.9 Epax
  • 9.10 KD Pharma Group
  • 9.11 Polaris Nutritional Lipids
  • 9.12 Solutex
  • 9.13 Veramaris
  • 9.14 Yield10 Bioscience
  • 9.15 AlgaeCytes
  • 9.16 Fermentalg
  • 9.17 Qualitas Health
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!